Kirksville College of Osteopathic Medicine
Kirksville, Missouri, 63501, United States
NCT Number: NCT00034112
The purpose of this study is to determine if osteopathic manipulative treatment (OMT) is effective for persons with emphysema as a component of their chronic obstructive pulmonary disease.
Looking for future studies?
Notify MeInterventional
Phase 2
Kirksville, Missouri, 63501, United States
OMT sessions are designed to improve chest wall compliance and diaphragmatic function which produce an immediate positive change in pulmonary function parameters and chest wall mobility. This research project will be a significant step in expanding the understanding of the role of OMT in the treatment of chronic lung disease. It is expected to yield evidence that OMT is an important adjunctive modality that improves pulmonary function, increases exercise tolerance, relieves dyspnea, and improves quality of life in those with COPD, and that would have widespread clinical application plus significant economic benefits.
Participants in this study will be randomly assigned to receive either OMT or sham treatments once a week for 13 weeks. Outcome measures will be obtained at baseline; immediately following the first treatment; at 4, 8, and 12 weeks after initiation of treatment; and 4 weeks after termination of the treatment. Outcome variables include pulmonary function tests; quality-of-life questionnaires (including emotional functioning, fatigue, and dyspnea); and measurements of exercise tolerance and chest wall mobility.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
National Center for Complementary and Integrative Health (NCCIH)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02099799
Behavior, Bronchial Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT00475007
COPD, Chronic Disease
Birmingham, Alabama, United States
View Trial DetailsNCT03073798
Behavior, Bronchial Diseases
View Trial DetailsNCT01051258
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD)
Vienna, Austria
View Trial Details